Inventor · disambiguated record
Nadia Anceriz
Also filed as: ANCERIZ NADIA
10 granted patents·3 pending applications·43 citations·filing 2015–2025
87Inventor score
Files withINNATE PHARMA13
Top patents by PatentIndex Score
13 records- 0195US11891444B2Variable regions for NKp46 binding proteinsINNATE PHARMA·Filed 2021·Granted Feb 6, 2024·3 cites·15 claims
- 0294US11267897B2Multispecific NK engager proteinINNATE PHARMA·Filed 2018·Granted Mar 8, 2022·8 cites·19 claims
- 0393US10113003B2Multispecific NK engager proteinsINNATE PHARMA·Filed 2016·Granted Oct 30, 2018·15 cites·28 claims
- 0488US11001629B2Variable regions for NKp46 binding proteinsINNATE PHARMA·Filed 2016·Granted May 11, 2021·7 cites·6 claims
- 0586US10519234B2NKp46 binding proteinsINNATE PHARMA·Filed 2015·Granted Dec 31, 2019·6 cites·12 claims
- 0680US11845795B2NKp46 binding proteinsINNATE PHARMA·Filed 2019·Granted Dec 19, 2023·1 cites·12 claims
- 0779US10736963B2Methods for detecting tissue infiltrating NK cellsINNATE PHARMA·Filed 2016·Granted Aug 11, 2020·2 cites·5 claims
- 0879US2024174748A1Variable regions for nkp46 binding proteinsINNATE PHARMA·Filed 2024·Application pending·0 cites
- 0978US11377492B2NKp46 binding agentsINNATE PHARMA·Filed 2018·Granted Jul 5, 2022·1 cites·16 claims
- 1078US2024141042A1MULTISPECIFIC NKp46 BINDING PROTEINSINNATE PHARMA·Filed 2023·Application pending·0 cites
- 1171US2025215107A1Multispecific nk engager proteinINNATE PHARMA·Filed 2025·Application pending·0 cites
- 1270US12365731B2NKp46 binding agentsINNATE PHARMA·Filed 2022·Granted Jul 22, 2025·0 cites·9 claims
- 1367US12252543B2Multispecific NK engager proteinINNATE PHARMA·Filed 2018·Granted Mar 18, 2025·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Nadia Anceriz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →